2024 Annual Meeting | C95 - Neurologic Intensive Care: Brain and Acute Spinal Cord Injury and Neuromuscular Disease

Date Monday 04/15/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | 605

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jan Claassen, MD, PhD

Topic(s) Neuro Trauma and Critical Care

Learning Objectives Participants should gain insights into the practice of neurological intensive care medicine including fundamental skills of diagnosis, management, and prognostication of acute neurological injuries; acquire knowledge about the approach to ICU management of patients with acute brain injuries such as elevation of intracranial pressure and herniation, diagnosis and ICU management of neuromuscular disorders and spinal cord injury, assessments and predictions, and ethical implications of caring for comatose patients.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM MDT	Introduction	Introduction Jan Claassen, MD, PhD
03:35 PM - 04:10 PM MDT	Speaker	Neuromuscular Disorders and Acute Spinal Cord Injuries in the ICU: Diagnosis, Management, and Treatment Diana Greene-Chandos, MD
04:10 PM - 04:45 PM MDT	Speaker	Acute Severe Brain Injury: Monitoring and Management Brandon P. Foreman, MD
04:10 PM - 05:20 PM MDT	Speaker	Acute Severe Brain Injury: Prognostication and Goals of Care Discussions Jan Claassen, MD, PhD
05:20 PM - 05:30 PM MDT	Speaker	Questions & Answers Jan Claassen, MD, PhD

Faculty Disclosures
Jan Claassen, MD, PhD	Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Diana Greene-Chandos, MD	Dr. Greene-Chandos has nothing to disclose.
Brandon P. Foreman, MD	Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB Pharma Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell, Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Foreman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma Inc.. The institution of Dr. Foreman has received research support from DOD/AMRMC. The institution of Dr. Foreman has received research support from Biogen, Inc.. The institution of Dr. Foreman has received research support from DOD/AFRL. The institution of Dr. Foreman has received research support from NSF SCH:INT. The institution of Dr. Foreman has received research support from NIH/NIBIB. The institution of Dr. Foreman has received research support from DOD/JWMRP. The institution of Dr. Foreman has received research support from Marinus Pharmaceuticals. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Natus Medical Incorporated. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Ceribell, Inc.. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Peer-to-peer program honoraria with Marinus Pharmaceuticals.